Ocular Side Effects of Bisphosphonates: A Review of Literature
- 1 February 2023
- journal article
- review article
- Published by Mary Ann Liebert Inc in Journal of Ocular Pharmacology and Therapeutics
- Vol. 39 (1), 3-16
- https://doi.org/10.1089/jop.2022.0094
Abstract
In rare cases, bisphosphonates are well established to cause ocular inflammation, presenting as uveitis, episcleritis, scleritis, orbital inflammation, and/or conjunctivitis. Some reports of bisphosphonate-associated neuro-ophthalmic complications also exist. We identified 101 reports in the literature relating to bisphosphonate-associated ocular complications. In a great majority of cases, symptoms resolve after discontinuation of the drug and anti-inflammatory treatment. Many cases recur if rechallenged with the same bisphosphonate. First-generation nonamino bisphosphonates, including clodronate and etidronate, are not associated with ocular inflammation. Only 2nd- and 3rd-generation amino bisphosphonates, including pamidronate, alendronate, risedronate, ibandronate, and zoledronate are associated with these complications. The mechanism of bisphosphonate-induced ocular inflammation may be related to activation of γ/δ T cells or M1 macrophages. Intravenous forms, such as pamidronate and zoledronate, tend to have higher rates and faster onset of ocular inflammation, generally presenting within days of infusion. In oral bisphosphonates, such as alendronate and risedronate, these complications present with more sporadic timing. Rates of complications are also higher when bisphosphonates are used for malignancy, as doses tend to be higher compared with doses for osteoporosis.Keywords
This publication has 132 references indexed in Scilit:
- Pro-inflammatory and anti-angiogenic effects of bisphosphonates on human cultured retinal pigment epithelial cellsBritish Journal of Ophthalmology, 2013
- Inflammatory eye reactions in patients treated with bisphosphonates and other osteoporosis medications: Cohort analysis using a national prescription databaseJournal of Bone and Mineral Research, 2012
- Inflammatory ocular adverse events with the use of oral bisphosphonates: a retrospective cohort studyCMAJ : Canadian Medical Association Journal, 2012
- A rare case of zolendronate infusion complication leading to glaucoma filtration surgeryClinical Ophthalmology, 2011
- Bisphosphonates pathwayPharmacogenetics and Genomics, 2011
- Therapeutic Effect of Oral Bisphosphonates on Choroidal Neovascularization in the Human EyeJournal of Ophthalmology, 2010
- Adverse Effects of Bisphosphonates: Implications for Osteoporosis ManagementMayo Clinic Proceedings, 2009
- A double-blinded, randomized controlled trial of zoledronate therapy for HIV-associated osteopenia and osteoporosisAIDS, 2009
- Acute uveitis following zoledronic acid infusionOman Journal of Ophthalmology, 2009
- Bisphosphonates: Mechanism of Action and Role in Clinical PracticeMayo Clinic Proceedings, 2008